Functional overlap between chondroitin and heparan sulfate proteoglycans during VEGF-induced sprouting angiogenesis (scientific article published on 16 February 2012)

Betaglycan inhibits TGF-beta signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan function

Q43773219

Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly

Q44850723

Heparan sulfate synthesized by mouse embryonic stem cells deficient in NDST1 and NDST2 is 6-O-sulfated but contains no N-sulfate groups

Q45023582

Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparins

Q46606789

Peripheral mural cell recruitment requires cell-autonomous heparan sulfate.

Q47929508

NG2 proteoglycan promotes angiogenesis-dependent tumor growth in CNS by sequestering angiostatin.

Q48648419

Decorin deficiency leads to impaired angiogenesis in injured mouse cornea.

Q52767198

Decorin suppresses tumor cell-mediated angiogenesis

Q61771867

Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A

Q73693211

Decorin inhibits endothelial migration and tube-like structure formation: role of thrombospondin-1

Q74077953

Nitrocellulose Filter Binding to Assess Binding of Glycosaminoglycans to Proteins

Q79210669

Heparan sulfate structure in mice with genetically modified heparan sulfate production

Q80413581

Heparan sulfate-protein interactions--a concept for drug design?

Q80541064

Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis

Q83296438

PDGF, TGF-β, and Heterotypic Cell–Cell Interactions Mediate Endothelial Cell–induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle Fate

Q24683266

Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse

Q28512852

Purification of the transforming growth factor-beta (TGF-beta) binding proteoglycan betaglycan

Q28568024

Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice

Q28586958

Derivation of completely cell culture-derived mice from early-passage embryonic stem cells

Q29547491

Angiogenesis in life, disease and medicine

Q29614539

Molecular regulation of angiogenesis and lymphangiogenesis

Q29616150

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

Q29616189

VEGF receptor signalling - in control of vascular function

Q29617256

PDGF (alpha)-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse

Q30640991

Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan

Q34312222

The transforming growth factor-beta receptor type III is a membrane proteoglycan. Domain structure of the receptor

Q34560678

Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall

Q35967045

Structural basis for fibroblast growth factor receptor activation

Q36111391

Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis

Q36119681

Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility

Q36258506

Interactions between heparan sulfate and proteins: the concept of specificity

Q36552851

Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction.

Q36798761

Building blood vessels--stem cell models in vascular biology

Q36834586

Decorin is a novel antagonistic ligand of the Met receptor

Q37263981

Decorin and its galactosaminoglycan chain: extracellular regulator of cellular function?

Q37272650

Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis.

Q37494563

Pericytes and vessel maturation during tumor angiogenesis and metastasis

Q37764322

Mice Deficient in Heparan Sulfate N-Deacetylase/N-Sulfotransferase 1

Q37784303

The conformation and structure of GAGs: recent progress and perspectives

Q37787520

Heparin amplifies platelet-derived growth factor (PDGF)- BB-induced PDGF alpha -receptor but not PDGF beta -receptor tyrosine phosphorylation in heparan sulfate-deficient cells. Effects on signal transduction and biological responses

Q38290891

Expression of the mouse mastocytoma glucosaminyl N-deacetylase/ N-sulfotransferase in human kidney 293 cells results in increased N-sulfation of heparan sulfate

Q41204799

Pericytes limit tumor cell metastasis

Q41916240

Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development

Q42276166

Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty

Q42792245

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

heparan sulfate proteoglycans

Q66589633

P304

page(s)

1255-1263

P577

publication date

2012-02-16

P1433

published in

Arteriosclerosis, Thrombosis, and Vascular Biology

Q4797542

P1476

title

Functional overlap between chondroitin and heparan sulfate proteoglycans during VEGF-induced sprouting angiogenesis

P478

volume

Reverse relations

cites work (P2860)

Q41200344	A glycan-based approach to therapeutic angiogenesis
Q90417370	Characterization of C. elegans Chondroitin Proteoglycans and Their Large Functional and Structural Heterogeneity; Evolutionary Aspects on Structural Differences Between Humans and the Nematode
Q38986588	Complex influence of dermatan sulphate on breast cancer cells.
Q89124983	Current and emerging therapies for corneal neovascularization
Q26797302	Determinants of Glycosaminoglycan (GAG) Structure
Q91619817	Dual Action of Sulfated Hyaluronan on Angiogenic Processes in Relation to Vascular Endothelial Growth Factor-A
Q47402381	Expanding the chondroitin glycoproteome of Caenorhabditis elegans
Q27011582	Heparan Sulfate Biosynthesis Enzymes in Embryonic Stem Cell Biology
Q38050077	Heparan sulfate biosynthesis: regulation and variability
Q38256873	Heparan sulfate in the regulation of neural differentiation and glioma development
Q36433979	Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo
Q34884277	Identification of chondroitin sulfate linkage region glycopeptides reveals prohormones as a novel class of proteoglycans
Q42587744	MicroRNA-24 suppression of N-deacetylase/N-sulfotransferase-1 (NDST1) reduces endothelial cell responsiveness to vascular endothelial growth factor A (VEGFA).
Q41002514	NDST2 (N-Deacetylase/N-Sulfotransferase-2) Enzyme Regulates Heparan Sulfate Chain Length
Q37310560	Nematodes join the family of chondroitin sulfate-synthesizing organisms: Identification of an active chondroitin sulfotransferase in Caenorhabditis elegans
Q91638143	Network Pharmacology-Based Strategy for Predicting Therapy Targets of Traditional Chinese Medicine Xihuang Pill on Liver Cancer
Q44433053	Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancer
Q28727414	On the roles and regulation of chondroitin sulfate and heparan sulfate in zebrafish pharyngeal cartilage morphogenesis
Q26823840	Pathophysiology of heparan sulphate: many diseases, few drugs
Q58063397	SLC10A7 mutations cause a skeletal dysplasia with amelogenesis imperfecta mediated by GAG biosynthesis defects
Q38973334	Sulfated glycosaminoglycans: their distinct roles in stem cell biology
Q35118601	The involvement of proteoglycans in the human plasma prekallikrein interaction with the cell surface.
Q55222850	The metalloproteinase-proteoglycans ADAMTS7 and ADAMTS12 provide an innate, tendon-specific protective mechanism against heterotopic ossification.